title: A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.
abstract: Identification of novel cancer genes for molecular therapy and diagnosis is a current focus of breast cancer research. Although a few small gene sets were identified as prognosis classifiers, more powerful models are still needed for the definition of effective gene sets for the diagnosis and treatment guidance in breast cancer. In the present study, we have developed a novel statistical approach for systematic analysis of intrinsic correlations of gene expression between development and tumorigenesis in mammary gland. Based on this analysis, we constructed a predictive model for prognosis in breast cancer that may be useful for therapy decisions. We first defined developmentally associated genes from a mouse mammary gland epithelial gene expression database. Then, we found that the cancer modulated genes were enriched in this developmentally associated genes list. Furthermore, the developmentally associated genes had a specific expression profile, which associated with the molecular characteristics and histological grade of the tumor. These result suggested that the processes of mammary gland development and tumorigenesis share gene regulatory mechanisms. Then, the list of regulatory genes both on the developmental and tumorigenesis process was defined an 835-member prognosis classifier, which showed an exciting ability to predict clinical outcome of three groups of breast cancer patients (the predictive accuracy 64∼72%) with a robust prognosis prediction (hazard ratio 3.3∼3.8, higher than that of other clinical risk factors (around 2.0-2.8)). In conclusion, our results identified the conserved molecular mechanisms between mammary gland development and neoplasia, and provided a unique potential model for mining unknown cancer genes and predicting the clinical status of breast tumors. These findings also suggested that developmental roles of genes may be important criteria for selecting genes for prognosis prediction in breast cancer.
authors.affiliation: Xiamen City Key Lab of Metabolism Disease & Metabolic Disease Research Center, Institute for Biomedical Research, Xiamen University, Xiamen, Fujian, China.
authors.forename: Yingpu
authors.initials: Y
authors.lastname: Tian
authors.forename: Baozhen
authors.initials: B
authors.lastname: Chen
authors.forename: Pengfei
authors.initials: P
authors.lastname: Guan
authors.forename: Yujia
authors.initials: Y
authors.lastname: Kang
authors.forename: Zhongxian
authors.initials: Z
authors.lastname: Lu
mesh_terms: D000465:Algorithms; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D016000:Cluster Analysis; D030541:Databases, Genetic; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D020407:Internet; D042361:Mammary Glands, Human / Q000378:metabolism* / Q000473:pathology*; D015233:Models, Statistical; D011379:Prognosis
references.citation: Breast Cancer Res Treat. 2010 Apr;120(3):655-61
references.pmid: 20204499
references.citation: Genes Dev. 2004 Mar 15;18(6):629-40
references.pmid: 15075291
references.citation: Breast Cancer Res. 2004;6(2):R92-109
references.pmid: 14979921
references.citation: J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):17-38
references.pmid: 12160083
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):5974-9
references.pmid: 12714683
references.citation: Breast Cancer Res. 2011 Jun 27;13(3):212
references.pmid: 21787441
references.citation: J Mammary Gland Biol Neoplasia. 2003 Jul;8(3):287-307
references.pmid: 14973374
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references.pmid: 11553815
references.citation: Int J Biochem Cell Biol. 2003 Jul;35(7):1034-51
references.pmid: 12672473
references.citation: Clin Cancer Res. 2008 May 15;14(10):2988-93
references.pmid: 18483364
references.citation: J Natl Cancer Inst. 2006 Feb 15;98(4):262-72
references.pmid: 16478745
references.citation: Proc R Soc Med. 1936 Oct;29(12):1577-626
references.pmid: 19990875
references.citation: Nat Rev Cancer. 2004 Mar;4(3):177-83
references.pmid: 14993899
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2532-7
references.pmid: 12610208
references.citation: Oncologist. 2005 Nov-Dec;10(10):766-79
references.pmid: 16314287
references.citation: PLoS Med. 2006 Jul;3(7):e232
references.pmid: 16800721
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
references.pmid: 12829800
references.citation: Breast Cancer Res. 2005;7(3):100-4
references.pmid: 15987438
references.citation: Nature. 2002 Jan 31;415(6871):530-6
references.pmid: 11823860
references.citation: J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):39-53
references.pmid: 15082917
references.citation: Curr Genomics. 2007 Jun;8(4):262-70
references.pmid: 18645595
references.citation: Endocr Relat Cancer. 2010 Sep 23;17(4):R245-62
references.pmid: 20647302
references.citation: Mol Cancer Ther. 2010 May;9(5):1120-7
references.pmid: 20423993
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Am J Pathol. 2003 Nov;163(5):1949-60
references.pmid: 14578194
references.citation: Cancer J. 2011 Mar-Apr;17(2):96-103
references.pmid: 21427553
references.citation: Cancer Res. 2005 Oct 1;65(19):8715-22
references.pmid: 16204040
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15149-54
references.pmid: 11742071
references.citation: Mol Endocrinol. 2002 Jun;16(6):1185-203
references.pmid: 12040007
references.citation: J Steroid Biochem Mol Biol. 2002 Feb;80(2):191-201
references.pmid: 11897503
references.citation: J Mammary Gland Biol Neoplasia. 1999 Apr;4(2):229-37
references.pmid: 10426402
references.citation: Breast Cancer Res Treat. 2005;89 Suppl 1:S17-26
references.pmid: 15770535
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12963-8
references.pmid: 12297621
references.citation: J Hepatol. 2005 Jun;42(6):860-9
references.pmid: 15885357
references.citation: Cancer Cell. 2004 Jun;5(6):607-16
references.pmid: 15193263
references.citation: Endocr Relat Cancer. 2006 Dec;13(4):1033-67
references.pmid: 17158753
references.citation: In Vitro Cell Dev Biol Anim. 1999 Sep;35(8):449-58
references.pmid: 10501084
references.citation: N Engl J Med. 2002 Dec 19;347(25):1999-2009
references.pmid: 12490681
references.citation: Breast Cancer Res. 2004;6(2):R75-91
references.pmid: 14979920
references.citation: Domest Anim Endocrinol. 2002 Jul;23(1-2):25-32
references.pmid: 12142223
references.citation: Genome Res. 2002 Jul;12(7):1112-20
references.pmid: 12097349
references.citation: J Clin Oncol. 2009 Jul 1;27(19):3185-91
references.pmid: 19364972
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6967-72
references.pmid: 12011455
references.citation: Surg Oncol. 2009 Dec;18(4):366-78
references.pmid: 19879448
references.citation: Clin Cancer Res. 2008 May 1;14(9):2601-8
references.pmid: 18451222
references.citation: Semin Cancer Biol. 2001 Oct;11(5):339-52
references.pmid: 11562176
references.citation: BMC Genomics. 2006 Apr 27;7:96
references.pmid: 16643655
references.citation: Annu Rev Cell Dev Biol. 2004;20:695-723
references.pmid: 15473857
references.citation: N Engl J Med. 2001 Feb 22;344(8):539-48
references.pmid: 11207349